Who we are | Boehringer Ingelheim UK
Who we are
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve outcomes and enhance lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,300 employees serve over 130 markets to build a healthier and more sustainable tomorrow.
Reporting suspected side effects and other adverse events for Boehringer Ingelheim medicinal products in the UK
Adverse Events
Our Company In The UK
Our Purpose - Delivering value through innovation with focus on three core pillars